Drug Topics - January 2009 - (Page 31)

FEATURED THIS MONTH: COUGHS AND COLDS healthy sinus, respiratory, and immune support. Sinupret’s herbs, formulated in a combination the company says does not exist in any other clinically tested natural product, have been studied extensively and have a long track record of safety in Europe and around the world. Sinupret for Kids promotes healthy drainage in the upper respiratory tract, improves air flow in the nose, and supports healthy mucus ﬂow in the nose and sinuses. Composed of a proprietary blend of European elder, sorrel, cowslip, European vervain, and gentian, the syrup is appropriate for children age 2 and older. Triaminic-D Multi-Symptom Cold, a new syrup for children over the age of 4, treats multiple cold-related symptoms. Its ingredients include an antihistamine, a cough suppressant, and a nasal decongestant. Another new product in this line is Triaminic Decongestant Spray Nasal & Sinus Congestion. Also new this season from Triaminic in its Theraflu line is Theraﬂu Warming Relief Flu & Sore Throat. The cherryflavored syrup contains a pain reliever and fever reducer (acetaminophen), cough suppressant, antihistamine, and nasal decongestant. The new Vicks Germ Free Warm Mist Humidiﬁer features a patented UV light chamber that kills up to 99.999 percent of bacteria, mold, and spores in the water vapor entering the air. Pediatricians recommend humidiﬁer use to help soothe cough symptoms and clear stuffy noses, a special concern with children, whose smaller nostrils get stuffed up more easily. Hyland’s is introducing Cold ’n Cough 4 Kids, a natural formula offering safe and effective symptom relief of common cold symptoms, including sneezing, sore throat, and congestion, that is safe for kids age 2 and older. Also new is Hyland’s Cough W W W.D R U GTO P I C S .C O M The DreamWorks Shrek humidi er will be available in February. Syrup with 100% Natural Honey 4 Kids. Hyland products contain no aspirin, acetaminophen, ibuprofen, naproxen, pseudoephedrine, or dextromethorphan. Most manufacturers have voluntarily modiﬁed their labels this year to warn that their products should not be given to children younger than 4 (where appropriate), following the FDA’s concern about risk of side effects in this patient group due to misuse, dosage errors, and accidental ingestion. Customers should be alerted to these label changes, as well as to the products’ actual ingredients. Too often, the stressing of ﬂavor ingredients and taste make them appear to be more “treat” than drug, particularly when formulated for children. Dana K. Cassell, a frequent contributor to Drug Topics, lives in North Stratford, New Hampshire. COURTESY OF DR. FRESH http://www.apothecaryrxllc.com http://www.apothecaryrxllc.com http://WWW.DRUGTOPICS.COM

Table of Contents Feed for the Digital Edition of Drug Topics - January 2009

Drug Topics - January 2009 Contents Letters Up Front Up Front in Depth Community Practice Drug Pipeline: What to Watch in 2009 OTC Community-Aquired MRSA Infections New Products Viewpoint

Drug Topics - January 2009

Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 3) Drug Topics - January 2009 - Contents (Page 4) Drug Topics - January 2009 - Contents (Page 5) Drug Topics - January 2009 - Contents (Page 6) Drug Topics - January 2009 - Contents (Page 7) Drug Topics - January 2009 - Contents (Page 8) Drug Topics - January 2009 - Contents (Page 9) Drug Topics - January 2009 - Contents (Page 10) Drug Topics - January 2009 - Contents (Page H1) Drug Topics - January 2009 - Contents (Page H2) Drug Topics - January 2009 - Contents (Page H1) Drug Topics - January 2009 - Contents (Page H2) Drug Topics - January 2009 - Contents (Page H3) Drug Topics - January 2009 - Contents (Page H4) Drug Topics - January 2009 - Contents (Page H5) Drug Topics - January 2009 - Contents (Page H6) Drug Topics - January 2009 - Contents (Page H7) Drug Topics - January 2009 - Contents (Page H8) Drug Topics - January 2009 - Contents (Page 13) Drug Topics - January 2009 - Up Front (Page 14) Drug Topics - January 2009 - Up Front (Page 15) Drug Topics - January 2009 - Up Front (Page 16) Drug Topics - January 2009 - Up Front (Page 17) Drug Topics - January 2009 - Up Front in Depth (Page 18) Drug Topics - January 2009 - Up Front in Depth (Page 19) Drug Topics - January 2009 - Community Practice (Page 20) Drug Topics - January 2009 - Community Practice (Page 20a) Drug Topics - January 2009 - Community Practice (Page 20b) Drug Topics - January 2009 - Community Practice (Page 21) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 22) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 23) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 24) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 25) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 26) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 27) Drug Topics - January 2009 - OTC (Page 28) Drug Topics - January 2009 - OTC (Page 29) Drug Topics - January 2009 - OTC (Page 30) Drug Topics - January 2009 - OTC (Page 31) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 32) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 33) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 34) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 35) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 36) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 37) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 38) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 39) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 40) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 41) Drug Topics - January 2009 - New Products (Page 42) Drug Topics - January 2009 - New Products (Page 43) Drug Topics - January 2009 - New Products (Page 44) Drug Topics - January 2009 - New Products (Page 45) Drug Topics - January 2009 - New Products (Page 46) Drug Topics - January 2009 - New Products (Page 47) Drug Topics - January 2009 - Viewpoint (Page 48) Drug Topics - January 2009 - Viewpoint (Page Cover3) Drug Topics - January 2009 - Viewpoint (Page Cover4) http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200912http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200911http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200910http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200909http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200908http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200907http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200906http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200905http://www.nxtbook.com/nxtbooks/advanstar/dt_200904http://www.nxtbook.com/nxtbooks/advanstar/dt_200903http://www.nxtbook.com/nxtbooks/advanstar/dt_200902http://www.nxtbook.com/nxtbooks/advanstar/dt_200901_v2http://www.nxtbook.com/nxtbooks/advanstar/dt_200901http://www.nxtbook.com/nxtbooks/advanstar/dt122908http://www.nxtbook.com/nxtbooks/advanstar/dt122208http://www.nxtbook.com/nxtbooks/advanstar/dt121508http://www.nxtbook.com/nxtbooks/advanstar/dt111008_v2http://www.nxtbook.com/nxtbooks/advanstar/dt120808http://www.nxtbook.com/nxtbooks/advanstar/dt120108http://www.nxtbook.com/nxtbooks/advanstar/dt112408http://www.nxtbook.com/nxtbooks/advanstar/dt111708http://www.nxtbook.com/nxtbooks/advanstar/dt111008http://www.nxtbook.com/nxtbooks/advanstar/dt110308http://www.nxtbook.com/nxtbooks/advanstar/dt102708http://www.nxtbook.com/nxtbooks/advanstar/dt102008http://www.nxtbook.com/nxtbooks/advanstar/dt101308http://www.nxtbook.com/nxtbooks/advanstar/dt100608http://www.nxtbook.com/nxtbooks/advanstar/dt092908http://www.nxtbook.com/nxtbooks/advanstar/dt092208http://www.nxtbook.com/nxtbooks/advanstar/dt090808http://www.nxtbook.com/nxtbooks/advanstar/dt090108http://www.nxtbook.com/nxtbooks/advanstar/dt082508http://www.nxtbook.com/nxtbooks/advanstar/dt081808http://www.nxtbook.com/nxtbooks/advanstar/dt081108http://www.nxtbook.com/nxtbooks/advanstar/dt080408http://www.nxtbook.com/nxtbooks/advanstar/dt072808http://www.nxtbook.com/nxtbooks/advanstar/dt072108http://www.nxtbook.com/nxtbooks/advanstar/dt070708http://www.nxtbook.com/nxtbooks/advanstar/dt063008http://www.nxtbook.com/nxtbooks/advanstar/dt062308http://www.nxtbook.com/nxtbooks/advanstar/dt061608http://www.nxtbook.com/nxtbooks/advanstar/dt060908http://www.nxtbook.com/nxtbooks/advanstar/dt060208http://www.nxtbook.com/nxtbooks/advanstar/dt052608http://www.nxtbook.com/nxtbooks/advanstar/dt051908http://www.nxtbook.com/nxtbooks/advanstar/dt051208http://www.nxtbook.com/nxtbooks/advanstar/dt042808http://www.nxtbook.com/nxtbooks/advanstar/dt042108http://www.nxtbook.com/nxtbooks/advanstar/dt041408http://www.nxtbook.com/nxtbooks/advanstar/dt040708http://www.nxtbook.com/nxtbooks/advanstar/dt033108http://www.nxtbook.com/nxtbooks/advanstar/dt032408http://www.nxtbook.com/nxtbooks/advanstar/dt031708http://www.nxtbook.com/nxtbooks/advanstar/dt031008http://www.nxtbook.com/nxtbooks/advanstar/dt030308http://www.nxtbook.com/nxtbooks/advanstar/dt022508http://www.nxtbook.com/nxtbooks/advanstar/dt021808http://www.nxtbook.com/nxtbooks/advanstar/dt021108http://www.nxtbook.com/nxtbooks/advanstar/dt020408http://www.nxtbook.com/nxtbooks/advanstar/dt012808http://www.nxtbook.com/nxtbooks/advanstar/dt012108http://www.nxtbook.com/nxtbooks/advanstar/dt011408http://www.nxtbook.com/nxtbooks/advanstar/dt010708http://www.nxtbook.com/nxtbooks/advanstar/dt121707http://www.nxtbook.com/nxtbooks/advanstar/dt121007http://www.nxtbook.com/nxtbooks/advanstar/dt120307http://www.nxtbook.com/nxtbooks/advanstar/dt112607http://www.nxtbook.com/nxtbooks/advanstar/dt111907http://www.nxtbook.com/nxtbooks/advanstar/dt111207http://www.nxtbook.com/nxtbooks/advanstar/dt110507http://www.nxtbook.com/nxtbooks/advanstar/dt102907http://www.nxtbook.com/nxtbooks/advanstar/dt102207http://www.nxtbook.com/nxtbooks/advanstar/dt101507http://www.nxtbook.com/nxtbooks/advanstar/dt100807http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.